142 related articles for article (PubMed ID: 12358644)
1. Safety of propoxyphene in dialysis patients.
Bailie GR; Johnson CA
Semin Dial; 2002; 15(5):375. PubMed ID: 12358644
[No Abstract] [Full Text] [Related]
2. About pain, opioids, and dialysis.
Mercadante S; Gambaro V
J Pain Symptom Manage; 2007 Jul; 34(1):5-6; author reply 6. PubMed ID: 17532175
[No Abstract] [Full Text] [Related]
3. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity.
Barkin RL; Barkin SJ; Barkin DS
Am J Ther; 2006; 13(6):534-42. PubMed ID: 17122535
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of tramadol in a hemodialysis patient.
Izzedine H; Launay-Vacher V; Abbara C; Aymard G; Bassilios N; Deray G
Nephron; 2002; 92(3):755-6. PubMed ID: 12372979
[No Abstract] [Full Text] [Related]
5. Why pick on propoxyphene? The evidence demands it.
Hutchison LC
J Ark Med Soc; 2010 Aug; 107(2):36-7. PubMed ID: 20806582
[TBL] [Abstract][Full Text] [Related]
6. The influence of propoxyphene withdrawal on opioid use in veterans.
Hayes CJ; Hudson TJ; Phillips MM; Bursac Z; Williams JS; Austin MA; Edlund MJ; Martin BC
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1180-8. PubMed ID: 26248742
[TBL] [Abstract][Full Text] [Related]
7. Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.
Davison SN; Mayo PR
J Opioid Manag; 2008; 4(6):335-6, 339-44. PubMed ID: 19192761
[TBL] [Abstract][Full Text] [Related]
8. Safety of chronic transdermal fentanyl use in patients receiving hemodialysis.
Han J; Saraf SL; Gordeuk VR; Gowhari M
Am J Health Syst Pharm; 2016 Jul; 73(13):947-8. PubMed ID: 27325876
[No Abstract] [Full Text] [Related]
9. Renal impairment: a challenge for opioid treatment? The role of buprenorphine.
Böger RH
Palliat Med; 2006; 20 Suppl 1():s17-23. PubMed ID: 16764217
[TBL] [Abstract][Full Text] [Related]
10. Pain assessment and management in hemodialysis patients.
De Castro C; Murphy L; Battistella M
CANNT J; 2013; 23(3):29-32; quiz 33-4. PubMed ID: 24344520
[No Abstract] [Full Text] [Related]
11. FDA raises safety issues concerning propoxyphene.
Aschenbrenner DS
Am J Nurs; 2010 Jan; 110(1):59-60. PubMed ID: 20032671
[No Abstract] [Full Text] [Related]
12. The suddenly speechless florist on chronic dialysis: the unexpected threats of a flower shop? Diagnosis: dialysis related Wernicke encephalopathy.
Barbara PG; Manuel B; Elisabetta M; Giorgio S; Fabio T; Valentina C; Emanuela M; Massimo B; Giuseppe S; Paolo SG
Nephrol Dial Transplant; 2006 Jan; 21(1):223-5. PubMed ID: 16280376
[No Abstract] [Full Text] [Related]
13. Propoxyphene-induced hypoglycemia in a patient with chronic renal failure.
Almirall J; Montoliu J; Torras A; Revert L
Nephron; 1989; 53(3):273-5. PubMed ID: 2797348
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of paracetamol and dextropropoxyphene in human plasma by liquid chromatography/tandem mass spectrometry: application to clinical bioequivalence studies.
Yin OQ; Lam SS; Chow MS
Rapid Commun Mass Spectrom; 2005; 19(6):767-74. PubMed ID: 15714600
[TBL] [Abstract][Full Text] [Related]
15. Propoxyphene and pain management in the elderly.
Mort JR; Schroeder SD
S D Med; 2009 Nov; 62(11):433-5. PubMed ID: 20128173
[TBL] [Abstract][Full Text] [Related]
16. Dextropropoxyphene: welcome withdrawal from a French hospital's formulary.
Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18629970
[TBL] [Abstract][Full Text] [Related]
17. Recurrent hypoglycemia in a hemodialysis patient related to propoxyphene treatment.
Lee HT; Tseng WC; Tarng DC
J Chin Med Assoc; 2007 Jul; 70(7):286-8. PubMed ID: 17631465
[TBL] [Abstract][Full Text] [Related]
18. Dextropropoxyphene: withdrawn in the EU. Withdrawn from pharmacies in France.
Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19746528
[No Abstract] [Full Text] [Related]
19. The pathology of dialysis.
Freemont AJ
Semin Dial; 2002; 15(4):227-31. PubMed ID: 12191022
[TBL] [Abstract][Full Text] [Related]
20. Dextropropoxyphene: withdrawal from the US market requested: harmful drug.
Prescrire Int; 2009 Aug; 18(102):166-7. PubMed ID: 19746529
[No Abstract] [Full Text] [Related]
[Next] [New Search]
